Anson Funds Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,000
| Closed | -$2.47M | – | 160 |
|
|
2023
Q3 | $2.47M | Hold |
68,000
| – | – | 0.5% | 34 |
|
|
2023
Q2 | $2.42M | Hold |
68,000
| – | – | 0.4% | 37 |
|
|
2023
Q1 | $2.42M | Hold |
68,000
| – | – | 0.4% | 43 |
|
|
2022
Q4 | $2.39M | Buy |
68,000
+40,000
| +143% | +$1.41M | 0.39% | 40 |
|
|
2022
Q3 | $824K | Hold |
28,000
| – | – | 0.1% | 156 |
|
|
2022
Q2 | $1.52M | Sell |
28,000
-16,000
| -36% | -$871K | 0.14% | 106 |
|
|
2022
Q1 | $2.4M | Buy |
+44,000
| New | +$2.4M | 0.19% | 84 |
|
|
2021
Q4 | – | Sell |
-48,000
| Closed | -$2.29M | – | 351 |
|
|
2021
Q3 | $2.29M | Hold |
48,000
| – | – | 0.22% | 104 |
|
|
2021
Q2 | $2.39M | Buy |
+48,000
| New | +$2.39M | 0.23% | 102 |
|
|
2020
Q1 | – | Sell |
-11,040
| Closed | -$648K | – | 78 |
|
|
2019
Q4 | $648K | Buy |
+11,040
| New | +$648K | 0.75% | 30 |
|